Nalu Bio
PrivateLast Round
Series A
Feb 28, 2023
Total Funding Raised
$13.5M
Company Overview
Nalu Bio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in February 2023.
Nalu Bio is a biotechnology company that has developed a drug discovery platform to accelerate the development of prescription and nonprescription health products targeting the endocannabinoid system (ECS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nalu Bio Comparables
Compare Nalu Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creo | 87% | |
| Hyasynth Biologicals Inc. | 82% | |
| FloraWorks | 77% |
For institutional investors. Book with your work email.
Nalu Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 28, 2023 | ||||
| Seed | Jan 7, 2021 |
For institutional investors. Book with your work email.
Nalu Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flybridge | Series A |
| Intrinsic Capital Partners | Series A |
| Portfolia Active Aging & Longevity Fund | Series A |
| Bonaventure Equity | Series A, Seed |
| Brown Angel Group | Series A |
| XFactor Ventures | Seed |
| Sacramento Angels | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 28, 2023
$12M round led by Intrinsic Capital Partners.
For institutional investors. Book with your work email.
Nalu Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nalu Bio's valuation, stock price, and market status.
Is Nalu Bio a public or private company?
Nalu Bio is a private company.
What is the current stock price of Nalu Bio?
Nalu Bio is a private company, so its shares have no public market price. Caplight tracks Nalu Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nalu Bio worth (valuation)?
Valuation information for Nalu Bio is not publicly available.
Can I buy Nalu Bio stock?
Nalu Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nalu Bio's last funding round?
Nalu Bio's most recent funding round was Series A on February 28, 2023.
Who are the main investors in Nalu Bio?
Key investors in Nalu Bio include Intrinsic Capital Partners, L37 Ventures.
Will Nalu Bio IPO soon?
No public IPO plans have been announced for Nalu Bio.
How can I track Nalu Bio secondary market activity?
Caplight tracks bids, offers, and trades in Nalu Bio's shares on secondary markets.